Adverse reactions to Acebutolol
- 1. Alteration of vision
- 2. Angina or myocardial crisis, potentially fatal
- 3. Arthralgia
- 4. Asthma, bronchospasm
- 5. Bradycardia
- 6. Cardiogenic shock
- 7. Chest pain
- 8. Constipation
- 9. Cough
- 10. Decrease in sodium excretion
- 11. Depression
- 12. Diarrhea
- 13. Diplopia
- 14. Dizziness
- 15. Dyspnoea
- 16. Epigastric pain
- 17. Fatigue, weakness
- 18. Fever
- 19. Gastritis
- 20. Headache
- 21. Hepatic enzymes increased
- 22. Hepatitis
- 23. Hyperhidrosis
- 24. Impotence
- 25. Insomnia
- 26. Interference with the ability to drive or operate machinery
- 27. Koilonychia
- 28. Lichen planus
- 29. Lupus-like syndrome
- 30. Muscle pain
- 31. Orthostatic hypotension
- 32. Peripheral vascular disease, worsening
- 33. Redness
- 34. Rhinitis
- 35. Rising titer of ANA (antinuclear antibodies)
- 36. Sickness
- 37. Skin rash
- 38. Sleep disturbance
- 39. Sleepiness
- 40. Type II diabetes
- 41. Vertigo
- 42. Vomit
- 43. Weight gain
If discontinue the medication abruptly.. Effect common to other beta-blockers
Rare. Sometimes in relation to rising titer of ANA.
Use this type of medication in asthmatics only low dose and can not use other alternatives.
Rare.
Very rare.. Only in case of overdose
Very rare.
Very rare.
Very rare.
Infrequent.
Very rare.
Not infrequently.
Not infrequently.
Very rare.
Very rare.
Infrequent.
Very rare.
Very rare.
Infrequent.
Slightly elevated levels.
Very rare.
No well-established relationship.
Incidence not more than 2% of patients.. Contradictory data in clinical trials
As with other beta blockers, acebutolol can sometimes lead to dizziness or tiredness..
No well-established relationship.
No well-established relationship.
Reversible after discontinuation of treatment.
Rare.
Rare.
Use the drug with great caution and vigilance in patients with impaired peripheral vascular flow.
Infrequent.
Frequent. After a year of treatment, may affect 15% of patients..
Rare.
Infrequent.
Rare.
Common reaction to various beta-blockers. The risk of diabetes is at least 28% higher in hypertensive patients treated with these substances, in contrast to other antihypertensive.
Not infrequently.
Rare.
No well-established relationship.